NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
This Quarter Return
+18.92%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$1.01B
AUM Growth
+$1.01B
(+25%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
10.52%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$64.2M |
| 2 |
Akebia Therapeutics
AKBA
|
$42.1M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 55.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vanguard Total Stock Market ETF
VTI
$526B
| $303M | 29.98% | 2,979,100 | – | – |
|
|
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $292M | 28.86% | 6,896,819 | – | – |
|
3
Vanguard FTSE Europe ETF
VGK
$26.8B
| $126M | 12.46% | 2,101,000 | – | – |
|
4
Inogen
INGN
$216M
| $122M | 12.09% | 5,419,449 | – | – |
|
|
ALDR
5
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $64.2M | 6.35% | +3,201,183 | New | +$64.2M |
|
|
6
Akebia Therapeutics
AKBA
$833M
| $42.1M | 4.17% | +1,516,387 | New | +$42.1M |
|
|
FLXN
7
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $24M | 2.38% | 1,783,131 | – | – |
|
|
WMGI
8
DELISTED
Wright Medical Group Inc
WMGI
| $18.4M | 1.82% | 585,759 | – | – |
|
|
TTPH
9
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $12.1M | 1.2% | 900,000 | – | – |
|